However, also CS-AML showed a trend toward an inferior CR rate as compared to de novo AML ( P =0.07), although this did not reach statistical significance, eventually due to the relative small number of patients in this group.
← all excerpts
Clinical significance of chromatin-spliceosome acute myeloid leukemia: a report from the Northern Italy Leukemia Group (NILG) randomized trial 02/06.
1
0.0700
0.0700